Health Catalyst, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Health Catalyst, Inc. on April 29, 2026. The report discloses corporate governance changes effective May 1, 2026, specifically the appointment of a new director and the expansion of the Board of Directors.
Key Financial Metrics
This filing does not contain financial performance data. There are no disclosures regarding revenue, profit, cash flow, margins, debt, or liquidity in this document.
Material Changes
- Board Expansion: The Board size is temporarily increasing from six (6) to seven (7) directors effective May 1, 2026.
- Director Appointment: Steven Nelson was appointed to fill a newly created vacant seat. He will serve as a Class II director until the 2027 Annual Meeting of Stockholders.
- Director Departure: The Board size is scheduled to reduce back to six (6) directors immediately prior to the 2026 Annual Meeting of Stockholders, as Matthew Kolb is not standing for re-election.
Guidance, Outlook, and Management Commentary
The filing includes no financial guidance, outlook, or management commentary regarding business operations. The primary focus is on the qualifications of the new appointee, Mr. Nelson, who previously served as EVP and President of Aetna, Inc., and held CEO roles at ChenMed LLC, Duly Health and Care, and UnitedHealthcare. No risks or contingencies related to financial performance are disclosed.
Investor Verification Checklist
- Verify the effective date of Steven Nelson's board seat (May 1, 2026) and his committee assignments, which are expected to be announced later.
- Confirm the timeline for the 2026 Annual Meeting of Stockholders to understand when the Board size will revert to six directors.
- Review the press release (Exhibit 99.1) for additional details on Mr. Nelson's background and the rationale for the appointment.
- Note that this filing contains no financial data; refer to the most recent Form 10-K or 10-Q for financial metrics.